Bioscience – Page 5 – Indianapolis Business Journal

Home » Bioscience

Articles

PANEL: Life sciences will see radically different future

May 13, 2013

IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues of venture capital, digital health innovations and research university entrepreneurship.

Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.

The following is an unedited transcript of the discussion.

IU medical school’s push to launch startups bears fruit

April 11, 2013

The Indiana University School of Medicine has launched 12 companies in the past 18 months—a burst of startup activity the school has never seen before.

Health care startups hungry for funds

January 31, 2013

Frustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create a dedicated funding stream that could total $30 million a year.

Zimmer’s earnings slip, but beat expectations

January 31, 2013

Fourth-quarter profit fell 2 percent at Zimmer Holdings Inc. due to large accounting charges, but still beat the estimates of Wall Street analysts.

BioCrossroads seed fund makes first investments

January 10, 2013

Local startups Esanex Inc. and Algaeon Inc. have received $500,000 and $250,000, respectively, from Indiana Seed Fund II, BioCrossroads’ second fund to help fledgling life sciences companies.

Nico raises $6.5 million more from existing investors

December 4, 2012

Indianapolis-based Nico Corp. wants to use its new round of capital to develop brain surgery products to address diseases that were often considered inoperable, such as metastatic brain cancer and intracerebral hemorrhages.

BioCrossroads has stoked state’s life sciences industry, but challenges remain

February 9, 2012

In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.

Dow Agro posts record fourth quarter profit

February 2, 2012

The Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the $72 million reported for the 2010 period.

BioCrossroads seeds upstart medical device maker

October 20, 2011

BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.

Ex-Dow Agro scientist makes plea in trade-secret case

September 16, 2011

A former Indiana scientist has agreed to plead guilty to charges of illegally sending trade secrets worth $300 million to China and Germany.

Medical implant maker plans move from northern Indiana

August 4, 2011

Rochester Medical Implants plans to move operations from Rochester to Noblesville in October. The company has 28 employees.

Indiana life sciences leaders look toward the future

July 27, 2011

Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue’s Discovery Park.

More life sciences firms opt to launch products in Europe

July 27, 2011

The U.S. Food and Drug Administration’s growing reputation for unpredictability is spurring some Indianapolis companies to join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations occurring in their backyards.

Tech district could boost Indianapolis’ convention business

July 20, 2011

The Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.

Lilly plans more investment in two-in-one drugs

June 27, 2011

Indianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act like two medicines in one. Lilly plans to add more scientists to back the effort.

City to roll out plan for 16th Street tech corridor

June 10, 2011

The city of Indianapolis plans to announce a major initiative to turn a stretch of 16th Street northwest of downtown into a hub for biotechnology and other high-tech companies.

Anson Group CEO thrives on helping clients work with FDA

June 9, 2011

Colleen Hittle became CEO and sole owner of the Indianapolis-based pharmaceutical and medical device consulting firm in April.

Life sciences logistics firm opens new tissue storage facility

May 27, 2011

BioStorage Technologies’ $4.6 million facility, located near the Indianapolis International Airport, will be used to prepare, store and transport tissue and blood samples.

Tax breaks approved for bioanalytical lab operator

April 7, 2011

The Metropolitan Development Commission on Wednesday preliminarily approved Advion BioServices Inc.’s request for a tax abatement to build a laboratory at Purdue Research Park in Indianapolis.

Bioanalytical researcher seeking abatement for new lab

April 5, 2011

Advion, a provider of bioanalytical research and a subsidiary of Ithaca, N.Y.-based Advion BioSciences Inc., is expected to open the 22,000-square-foot lab in mid-May with 49 employees, according to the company’s application.

« Previous 1 … 3 4 5 6 7 Next »

This Week

JAN. 17-23, 2025

Digital Edition

Hogsett team remains upbeat as MLS discussions grow quiet

Mickey Shuey

For large law firms, Statehouse lobbying is a must-do

Greg Weaver

Film to focus on activist and medical debt issue

Dave Lindquist

Previous Issues See Full Issue

Events

Excellence in Health Care awards honors individuals or organizations in the central Indiana health care industry who are making a significant impact on the quality of health care in the Indianapolis metropolitan area.

RSVP HERE!

On February 27th, IBJ will partner with Gleaners to provide keen insight into relevant issues in food insecurity and health trends.

RSVP Here!

More events

Nominations

Each year the Indianapolis Business Journal recognizes 40 individuals who have made their mark in their profession before the young age of 40. Who will be named to this year's class? Be among the first to meet the 2025 Forty Under 40 honorees on Thursday, April 10th!

NOMINATE HERE!

IBJ’s Fast 25 event unveils our exclusive ranking of fastest-growing privately held companies. Companies are ranked based on their revenue growth over a two-year period. Stick around for our cocktail reception to network and enjoy complimentary drinks & hors d'oeuvres.

NOMINATE HERE!